↓ Skip to main content

Drug Targets in Kinetoplastid Parasites

Overview of attention for book
Attention for Chapter 9: DNA Topoisomerases of Leishmania: The Potential Targets for Anti-Leishmanial Therapy
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
39 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
DNA Topoisomerases of Leishmania: The Potential Targets for Anti-Leishmanial Therapy
Chapter number 9
Book title
Drug Targets in Kinetoplastid Parasites
Published in
Advances in experimental medicine and biology, March 2008
DOI 10.1007/978-0-387-77570-8_9
Pubmed ID
Book ISBNs
978-0-387-77569-2, 978-0-387-77570-8
Authors

Das BB, Ganguly A, Majumder HK, Benu Brata Das, Agneyo Ganguly, Hemanta K. Majumder

Abstract

Protozoan parasites of the genus Leishmania cause severe diseases that threaten human beings, both for the high mortality rates involved and the economic loss resulting from morbidity, primarily in the tropical and subtropical areas. This ancient eukaryote shows variable genetic diversity in their life cycle, wherein DNA topoisomerases play a key role in cellular processes affecting the topology and organization ofintracellular DNA. Kinetoplastid topoisomerases offer most attractive targets for their structural diversity from other eukaryotic counterparts and their indispensable function in cell biology Therefore, understanding the biology of kinetoplastid topoisomerases and the components and steps involved in this intricate process provide opportunities for target based drug designing against protozoan parasitic diseases.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 39 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 18%
Researcher 5 13%
Student > Master 5 13%
Professor > Associate Professor 4 10%
Student > Bachelor 3 8%
Other 12 31%
Unknown 3 8%
Readers by discipline Count As %
Medicine and Dentistry 7 18%
Agricultural and Biological Sciences 7 18%
Biochemistry, Genetics and Molecular Biology 5 13%
Chemistry 5 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Other 5 13%
Unknown 8 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 October 2014.
All research outputs
#20,241,019
of 22,768,097 outputs
Outputs from Advances in experimental medicine and biology
#3,955
of 4,928 outputs
Outputs of similar age
#78,139
of 81,283 outputs
Outputs of similar age from Advances in experimental medicine and biology
#4
of 5 outputs
Altmetric has tracked 22,768,097 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,928 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 81,283 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one.